LAPTM4B and lung adenocarcinoma: Similar to our previous findings of declined serum LAPTM4B levels in postchemotherapy samples in lung adenocarcinoma [42], serum LAPTM4B levels were significantly decreased in BC patients after adjuvant therapy.